A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Clinical trial NCT02201290 · COMPLETED

Trial details

NCT number: NCT02201290
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2013-06-18
Primary completion: 2017-07-04
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.